Myeloperoxidase predicts risk of vasculopathic events in hemizgygous males with Fabry disease
Fabry disease results in a global vasculopathy leading to early-onset stroke and renal and cardiac failure. We found that random myeloperoxidase in serum and plasma was significantly elevated in 73 consecutive male patients with Fabry disease. Random serum myeloperoxidase level in men predicted the...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
December 12, 2006
|
| In: |
Neurology
Year: 2006, Jahrgang: 67, Heft: 11, Pages: 2045-2047 |
| ISSN: | 1526-632X |
| DOI: | 10.1212/01.wnl.0000247278.88077.09 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1212/01.wnl.0000247278.88077.09 Verlag, Volltext: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1950664/ 
|
| Verfasserangaben: | C.R. Kaneski, MS, D.F. Moore, MD, PhD, DIC, M. Ries, MD, MHSc, G.C. Zirzow, BS, R. Schiffmann, MD, MHSc |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1665725222 | ||
| 003 | DE-627 | ||
| 005 | 20230427160224.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190515s2006 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1212/01.wnl.0000247278.88077.09 |2 doi | |
| 035 | |a (DE-627)1665725222 | ||
| 035 | |a (DE-599)KXP1665725222 | ||
| 035 | |a (OCoLC)1341224550 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kaneski, Christine R. |e VerfasserIn |0 (DE-588)1186197676 |0 (DE-627)1665725605 |4 aut | |
| 245 | 1 | 0 | |a Myeloperoxidase predicts risk of vasculopathic events in hemizgygous males with Fabry disease |c C.R. Kaneski, MS, D.F. Moore, MD, PhD, DIC, M. Ries, MD, MHSc, G.C. Zirzow, BS, R. Schiffmann, MD, MHSc |
| 264 | 1 | |c December 12, 2006 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 15.05.2019 | ||
| 520 | |a Fabry disease results in a global vasculopathy leading to early-onset stroke and renal and cardiac failure. We found that random myeloperoxidase in serum and plasma was significantly elevated in 73 consecutive male patients with Fabry disease. Random serum myeloperoxidase level in men predicted the risk of a Fabry vasculopathy-related event in subsequent years. Long-term enzyme replacement therapy did not reduce myeloperoxidase level or eliminate the risk of vasculopathic events. | ||
| 700 | 1 | |a Moore, David F. |e VerfasserIn |0 (DE-588)1185726535 |0 (DE-627)1665088176 |4 aut | |
| 700 | 1 | |a Ries, Markus |d 1971- |e VerfasserIn |0 (DE-588)136385338 |0 (DE-627)582068479 |0 (DE-576)300993358 |4 aut | |
| 700 | 1 | |a Zirzow, G. C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schiffmann, Raphael |e VerfasserIn |0 (DE-588)111475126X |0 (DE-627)869019376 |0 (DE-576)477474578 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neurology |d Philadelphia, Pa. : Wolters Kluwer, 1951 |g 67(2006), 11, Seite 2045-2047 |h Online-Ressource |w (DE-627)302718524 |w (DE-600)1491874-2 |w (DE-576)079876609 |x 1526-632X |7 nnas |a Myeloperoxidase predicts risk of vasculopathic events in hemizgygous males with Fabry disease |
| 773 | 1 | 8 | |g volume:67 |g year:2006 |g number:11 |g pages:2045-2047 |g extent:3 |a Myeloperoxidase predicts risk of vasculopathic events in hemizgygous males with Fabry disease |
| 856 | 4 | 0 | |u https://doi.org/10.1212/01.wnl.0000247278.88077.09 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1950664/ |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190515 | ||
| 993 | |a Article | ||
| 994 | |a 2006 | ||
| 998 | |g 136385338 |a Ries, Markus |m 136385338:Ries, Markus |p 3 | ||
| 999 | |a KXP-PPN1665725222 |e 3476078221 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"recId":"302718524","pubHistory":["1.1951 -"],"disp":"Myeloperoxidase predicts risk of vasculopathic events in hemizgygous males with Fabry diseaseNeurology","note":["Gesehen am 12.12.23"],"id":{"issn":["1526-632X"],"zdb":["1491874-2"],"eki":["302718524"]},"title":[{"title":"Neurology","title_sort":"Neurology","subtitle":"official journal of the American Academy of Neurology"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"dateIssuedDisp":"1951-","publisherPlace":"Philadelphia, Pa. ; [Erscheinungsort nicht ermittelbar] ; Hagerstown, Md.","dateIssuedKey":"1951","publisher":"Wolters Kluwer ; Ovid ; Lippincott Williams & Wilkins"}],"part":{"text":"67(2006), 11, Seite 2045-2047","issue":"11","volume":"67","year":"2006","extent":"3","pages":"2045-2047"},"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"3 S."}],"person":[{"roleDisplay":"VerfasserIn","family":"Kaneski","display":"Kaneski, Christine R.","role":"aut","given":"Christine R."},{"roleDisplay":"VerfasserIn","family":"Moore","given":"David F.","display":"Moore, David F.","role":"aut"},{"family":"Ries","roleDisplay":"VerfasserIn","role":"aut","display":"Ries, Markus","given":"Markus"},{"family":"Zirzow","roleDisplay":"VerfasserIn","role":"aut","display":"Zirzow, G. C.","given":"G. C."},{"roleDisplay":"VerfasserIn","family":"Schiffmann","given":"Raphael","display":"Schiffmann, Raphael","role":"aut"}],"name":{"displayForm":["C.R. Kaneski, MS, D.F. Moore, MD, PhD, DIC, M. Ries, MD, MHSc, G.C. Zirzow, BS, R. Schiffmann, MD, MHSc"]},"language":["eng"],"origin":[{"dateIssuedKey":"2006","dateIssuedDisp":"December 12, 2006"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 15.05.2019"],"id":{"eki":["1665725222"],"doi":["10.1212/01.wnl.0000247278.88077.09"]},"title":[{"title":"Myeloperoxidase predicts risk of vasculopathic events in hemizgygous males with Fabry disease","title_sort":"Myeloperoxidase predicts risk of vasculopathic events in hemizgygous males with Fabry disease"}],"recId":"1665725222"} | ||
| SRT | |a KANESKICHRMYELOPEROX1220 | ||